Mar. Drugs 2013, 11(5), 1490-1491; doi:10.3390/md11051490

Correction
Correction: Kim, G.-Y. et al. Pectenotoxin-2 from Marine Sponges: A Potential Anti-Cancer Agent-A Review. Mar. Drugs 2011, 9, 2176-2187
Gi-Young Kim 1, Wun-Jae Kim 2 and Yung Hyun Choi 3,4,*
1
Laboratory of Immunobiology, Department of Marine Life Sciences, Jeju National University, Jeju 690-756, Korea; E-Mail: immunkim@cheju.ac.kr
2
Department of Urology, Chungbuk National University College of Medicine, Cheongju 361-763, Korea; E-Mail: wjkim@chungbuk.ac.kr
3
Department of Biochemistry, College of Oriental Medicine, Dongeui University, Busan 614-052, Korea
4
Department of Biomaterial Control (BK21 program), Graduate School, and Blue-Bio Industry RIC, Dongeui University, Busan 614-052, Korea
*
Author to whom correspondence should be addressed; E-Mail: choiyh@deu.ac.kr; Tel.: +82-51-850-7413; Fax: +82-51-853-4036.
Received: 15 March 2013 / Accepted: 3 May 2013 / Published: 7 May 2013

It has been brought to our attention that the Figure 1 (page 2177) in our published paper [1] has some errors, we would like to change it to the following one:

Marinedrugs 11 01490 g001 200
Figure 1. Chemical structure of PTX-2 (A) (reproduced from [2]), Molecular Weight: 859.1; Molecular Formula: C47H70O14, and confocal imaging of actin cytoskeleton and morphology of hepatic cells (B). Panels (a) and (c) are fluorescence and transmission photographs of the control cells, respectively; panels (b) and (d) are from cells treated with 200 nM PTX-2. Arrows point to differences on the F-actin distribution between control and treated cells (bundles and dots, respectively). One cell is outlined in controls (c) and in cells incubated with PTX-2 (d) to show morphological changes. Images are representative of three independent experiments. Scale bar = 50 μm. (Note: Figure 1B is reproduced with permission from [3], copyright © 2008 British Pharmacological Society).

Click here to enlarge figure

Figure 1. Chemical structure of PTX-2 (A) (reproduced from [2]), Molecular Weight: 859.1; Molecular Formula: C47H70O14, and confocal imaging of actin cytoskeleton and morphology of hepatic cells (B). Panels (a) and (c) are fluorescence and transmission photographs of the control cells, respectively; panels (b) and (d) are from cells treated with 200 nM PTX-2. Arrows point to differences on the F-actin distribution between control and treated cells (bundles and dots, respectively). One cell is outlined in controls (c) and in cells incubated with PTX-2 (d) to show morphological changes. Images are representative of three independent experiments. Scale bar = 50 μm. (Note: Figure 1B is reproduced with permission from [3], copyright © 2008 British Pharmacological Society).
Marinedrugs 11 01490 g001 1024

References

  1. Kim, G.-Y.; Kim, W.-J.; Choi, Y.H. Pectenotoxin-2 from Marine Sponges: A Potential Anti-Cancer Agent—A Review. Mar. Drugs 2011, 9, 2176–2187.
  2. Pectenotoxin 2—Compound Summary (CID 6437385). Available online: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=6437385 (accessed on 8 February 2013).
  3. Espiña, B.; Louzao, M.C.; Ares, I.R.; Cagide, E.; Vieytes, M.R.; Vega, F.V.; Rubiolo, J.A.; Miles, C.O.; Suzuki, T.; Yasumoto, T.; et al. Cytoskeletal toxicity of pectenotoxins in hepatic cells. Br. J. Pharmacol. 2008, 155, 934–944, doi:10.1038/bjp.2008.323.
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert